BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36208651)

  • 1. Volumetric changes in gray matter after radiotherapy detected with longitudinal magnetic resonance imaging in glioma patients.
    Lee HI; Kang MK; Hwang K; Kim CY; Kim YJ; Suh KJ; Choi BS; Choe G; Kim IA; Jang BS
    Radiother Oncol; 2022 Nov; 176():157-164. PubMed ID: 36208651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voxel based morphometry-detected white matter volume loss after multi-modality treatment in high grade glioma patients.
    de Groot JD; van Dijken BRJ; van der Weide HL; Enting RH; van der Hoorn A
    PLoS One; 2023; 18(5):e0275077. PubMed ID: 37134064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent volume loss in subcortical deep grey matter structures after cranial radiotherapy.
    Nagtegaal SHJ; David S; Philippens MEP; Snijders TJ; Leemans A; Verhoeff JJC
    Clin Transl Radiat Oncol; 2021 Jan; 26():35-41. PubMed ID: 33294645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal brain volumetrics in glioma survivors.
    McDonald AM; Murdaugh DL; Heinzman KA; Cardan RA; Jacob J; Fiveash JB; Nabors LB; Cooper CA; Hoyle JM; Milner D; Cardenas CE
    J Neurosurg; 2024 Apr; ():1-8. PubMed ID: 38669700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Brain volumetric MRI study in healthy elderly persons using statistical parametric mapping].
    Miyahira Y; Yu J; Hiramatsu K; Shimazaki Y; Takeda Y
    Seishin Shinkeigaku Zasshi; 2004; 106(2):138-51. PubMed ID: 15052785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restructuring of contralateral gray matter volume associated with cognition in patients with unilateral temporal lobe glioma before and after surgery.
    Hu G; Hu X; Yang K; Liu D; Xue C; Liu Y; Xiao C; Zou Y; Liu H; Chen J
    Hum Brain Mapp; 2020 May; 41(7):1786-1796. PubMed ID: 31883293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation Dose-Dependent Hippocampal Atrophy Detected With Longitudinal Volumetric Magnetic Resonance Imaging.
    Seibert TM; Karunamuni R; Bartsch H; Kaifi S; Krishnan AP; Dalia Y; Burkeen J; Murzin V; Moiseenko V; Kuperman J; White NS; Brewer JB; Farid N; McDonald CR; Hattangadi-Gluth JA
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):263-269. PubMed ID: 28068234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interim Tumor Progression and Volumetric Changes of Surgical Cavities during the Surgery-to-Radiotherapy Interval in Anaplastic Gliomas: Implications for Additional Pre-radiotherapy Magnetic Resonance Imaging.
    Wee CW; Kim IH; Park CK; Kim JW
    Cancer Res Treat; 2020 Apr; 52(2):524-529. PubMed ID: 31671935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of gray matter atrophy in seizure-free patients with temporal lobe epilepsy.
    Alvim MK; Coan AC; Campos BM; Yasuda CL; Oliveira MC; Morita ME; Cendes F
    Epilepsia; 2016 Apr; 57(4):621-9. PubMed ID: 26865066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-Dependent Cortical Thinning After Partial Brain Irradiation in High-Grade Glioma.
    Karunamuni R; Bartsch H; White NS; Moiseenko V; Carmona R; Marshall DC; Seibert TM; McDonald CR; Farid N; Krishnan A; Kuperman J; Mell L; Brewer JB; Dale AM; Hattangadi-Gluth JA
    Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):297-304. PubMed ID: 26853338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain gray matter reduction and premature brain aging after breast cancer chemotherapy: a longitudinal multicenter data pooling analysis.
    de Ruiter MB; Deardorff RL; Blommaert J; Chen BT; Dumas JA; Schagen SB; Sunaert S; Wang L; Cimprich B; Peltier S; Dittus K; Newhouse PA; Silverman DH; Schroyen G; Deprez S; Saykin AJ; McDonald BC
    Brain Imaging Behav; 2023 Oct; 17(5):507-518. PubMed ID: 37256494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ionizing radiation on the human brain: white matter and gray matter T1 in pediatric brain tumor patients treated with conformal radiation therapy.
    Steen RG; Koury B S M; Granja CI; Xiong X; Wu S; Glass JO; Mulhern RK; Kun LE; Merchant TE
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):79-91. PubMed ID: 11163500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation-induced changes in normal-appearing gray matter in patients with nasopharyngeal carcinoma: a magnetic resonance imaging voxel-based morphometry study.
    Lv XF; Zheng XL; Zhang WD; Liu LZ; Zhang YM; Chen MY; Li L
    Neuroradiology; 2014 May; 56(5):423-30. PubMed ID: 24609527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness.
    Torres US; Duran FL; Schaufelberger MS; Crippa JA; Louzã MR; Sallet PC; Kanegusuku CY; Elkis H; Gattaz WF; Bassitt DP; Zuardi AW; Hallak JE; Leite CC; Castro CC; Santos AC; Murray RM; Busatto GF
    Neuroimage Clin; 2016; 12():1-15. PubMed ID: 27354958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of Deep Gray Matter Atrophy in Multiple Sclerosis: A Multimodal MRI Study.
    Pontillo G; Cocozza S; Lanzillo R; Russo C; Stasi MD; Paolella C; Vola EA; Criscuolo C; Borrelli P; Palma G; Tedeschi E; Morra VB; Elefante A; Brunetti A
    AJNR Am J Neuroradiol; 2019 Jan; 40(1):99-106. PubMed ID: 30573464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of gray-matter multiple sclerosis lesions using double inversion recovery, diffusion, contrast-enhanced, and volumetric MRI.
    Parra Corral MA; Govindarajan ST; Stefancin P; Bangiyev L; Coyle PK; Duong TQ
    Mult Scler Relat Disord; 2019 Jun; 31():74-81. PubMed ID: 30951968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between gray matter volume and cognitive learning in CIS patients on disease-modifying treatment.
    Uher T; Benedict RH; Horakova D; Bergsland N; Dusankova JB; Tyblova M; Ramasamy DP; Seidl Z; Vaneckova M; Krasensky J; Havrdova E; Zivadinov R
    J Neurol Sci; 2014 Dec; 347(1-2):229-34. PubMed ID: 25456460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year regional grey and white matter volume changes with natalizumab and fingolimod.
    Preziosa P; Rocca MA; Pagani E; Storelli L; Rodegher M; Moiola L; Filippi M
    J Neurol Neurosurg Psychiatry; 2020 May; 91(5):493-502. PubMed ID: 32111638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapy.
    Raschke F; Witzmann K; Seidlitz A; Wesemann T; Jentsch C; Platzek I; van den Hoff J; Kotzerke J; Beuthien-Baumann B; Baumann M; Linn J; Krause M; Troost EGC
    Clin Transl Radiat Oncol; 2022 Sep; 36():99-105. PubMed ID: 35965663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy.
    Rieken S; Habermehl D; Giesel FL; Hoffmann C; Burger U; Rief H; Welzel T; Haberkorn U; Debus J; Combs SE
    Radiother Oncol; 2013 Dec; 109(3):487-92. PubMed ID: 23953407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.